Fibrolamellar hepatocellular carcinoma with multiple lung metastases treated with multidisciplinary therapy

8Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

A 20-year old man was diagnosed with fibrolamellar hepatocellular carcinoma (FLHCC) with multiple lung metastases, and chemotherapy with FOLFOX was administered. Contrast enhanced CT after 3 cycles of FOLFOX showed no disease progression. We therefore performed surgical resection and radiofrequency abla-tion of the liver lesions and lung metastases, after obtaining the patient’s informed consent. The liver lesions and lung metastases tested positive for DNAJB1-PRKACA. The treatment for FLHCC with extrahepatic metastasis has not been established; however, in a few cases, good long-term prognoses were obtained with multidisciplinary therapy. We herein report a case of FLHCC with multiple lung metastases that was treated with multidisciplinary therapies.

Cite

CITATION STYLE

APA

Tanaka, H., Hijioka, S., Iwaya, H., Mizuno, N., Kuwahara, T., Okuno, N., … Hara, K. (2018). Fibrolamellar hepatocellular carcinoma with multiple lung metastases treated with multidisciplinary therapy. Internal Medicine, 57(24), 3537–3543. https://doi.org/10.2169/internalmedicine.1243-18

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free